Finch Therapeutics Group, Inc. Quarterly Debt-to-equity in % from Q3 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Finch Therapeutics Group, Inc. quarterly Debt-to-equity history and growth rate from Q3 2021 to Q2 2024.
  • Finch Therapeutics Group, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 157 %, a 99.5% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 157 +78.3 +99.5% Jun 30, 2024
Q1 2024 142 +81.6 +134% Mar 31, 2024
Q4 2023 136 +95 +231% Dec 31, 2023
Q3 2023 101 +73.2 +263% Sep 30, 2023
Q2 2023 78.6 +61.5 +359% Jun 30, 2023
Q1 2023 60.9 +50.8 +506% Mar 31, 2023
Q4 2022 41.1 +31.6 +331% Dec 31, 2022
Q3 2022 27.8 +12.7 +83.4% Sep 30, 2022
Q2 2022 17.1 Jun 30, 2022
Q1 2022 10 Mar 31, 2022
Q4 2021 9.55 Dec 31, 2021
Q3 2021 15.2 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.